Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000413454 | SCV000492030 | likely pathogenic | not provided | 2016-11-29 | criteria provided, single submitter | clinical testing | The R160P variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. This variant has been observed apparently de novo at GeneDx. The R160P variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The R160P variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in nearby residues (A158T/V, H165Y/P/Q) have been reported in the Human Gene Mutation Database in association with campomelic dysplasia (Stenson et al., 2014), supporting the functional importance of this region of the protein. |